Product Aggregation in Bioprocessing: Origins, Prevention, and Removal
Source: MilliporeSigma
The tendency for most biological products to self-associate and aggregate, often irreversibly, is a considerable challenge in process management and design, as aggregated product leads to patient safety concerns, process challenges and lost yield. Therefore, it is important to reduce the aggregation of the biological product during processing and to remove aggregates efficiently and effectively.
In this webinar you will learn:
- How and why biological product aggregates form within a bioprocessing environment, based on process conditions and biochemistry, and how these are detected
- Strategies for reducing the risk of aggregation at each stage of the process
- Proven methods for removal of aggregates effectively
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development
X
Subscribe to Biosimilar Development
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more